Free Access
J Extra Corpor Technol
Volume 46, Number 1, March 2014
Page(s) 69 - 76
Published online 15 March 2014
  1. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009;13:154–175. [CrossRef] [PubMed] [Google Scholar]
  2. Bembea MM, Annich G, Rycus P, Oldenburg G, Berkowitz I, Pronovost P. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey. Pediatr Crit Care Med. 2013;14:e77. [CrossRef] [PubMed] [Google Scholar]
  3. Hirsh J, Warkentin TE, Shaughnessy SG, et al. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(Suppl):64S–94S. [CrossRef] [PubMed] [Google Scholar]
  4. Smythe MA, Caffee A. Anticoagulation monitoring. Journal of Pharmacy Practice. 2004;17:317–326. [CrossRef] [Google Scholar]
  5. Srinivasan D, Watzak B. Anticoagulant use in real time. J Pharm Pract. 2013;26:270–279. [CrossRef] [PubMed] [Google Scholar]
  6. Mueller XM, Tevaearai HT, Jegger D, Augstburger M, Goddar G, von Segesser LK. Antithrombotic properties of trillium coated connectors. ASAIO J. 2002;48:483–486. [CrossRef] [PubMed] [Google Scholar]
  7. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman & Hall/CRC; 1998. [Google Scholar]
  8. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose–response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685–689. [CrossRef] [Google Scholar]
  9. Litwin SB, Mitra SK, Von Colditz R, et al. Use of activated clotting time for monitoring anticoagulation during cardiopulmonary bypass in infants and children with congenital heart disease. Cardiovasc Dis. 1981;8:364–371. [Google Scholar]
  10. Reiner JS, Coyne KS, Lundergan CF, Ross AM. Bedside monitoring of heparin therapy: Comparison of activated clotting time to activated partial thromboplastin time. Cathet Cardiovasc Diagn. 1994;32:49–52. [CrossRef] [Google Scholar]
  11. Smythe MA, Koerber JM, Nowak SN, et al. Correlation between activated clotting time and activated partial thromboplastin times. Ann Pharmacother. 2002;36:7–11. [CrossRef] [PubMed] [Google Scholar]
  12. Nankervis CA, Preston TJ, Dysart KC, et al. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J. 2007;53:111–114. [CrossRef] [PubMed] [Google Scholar]
  13. Baird CW, Zurakowski D, Robinson B, et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: Impact of activated clotting time and heparin dose on survival. Ann Thorac Surg. 2007;83:912–919. [CrossRef] [Google Scholar]
  14. Maul TM, Wolff EL, Kuch BA, Rosendorff A, Morell VO, Wearden PD. Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2012;13:e363–e371. [CrossRef] [PubMed] [Google Scholar]
  15. Bembea MM, Schwartz JM, Shah N, et al. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation. ASAIO J. 2013;59:63–68. [CrossRef] [PubMed] [Google Scholar]
  16. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165–172. [CrossRef] [PubMed] [Google Scholar]
  17. Williams MD, Chalmers EA, Gibson BE; Haemostasis, Thrombosis Task Force, British Committee for Standards in Haematology. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119:295–309. [CrossRef] [Google Scholar]
  18. Weitz JI. Low-molecular-weight heparins. N Engl J Med. 1997;337:688–698. [CrossRef] [PubMed] [Google Scholar]
  19. Stammers AH, Willett L, Fristoe L, et al. Coagulation monitoring during extracorporeal membrane oxygenation: The role of thromboelastography. J Extra Corpor Technol. 1995;27:137–145. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.